The biological effects of many environmental toxins are mediated by genes containing Per-Arnt-Sim (PAS) domains, the aryl hydrocarbon receptor (AhR), and AhR nuclear translocator. Because these transcription factors interact with other PAS genes that form the circadian clockworks in mammals, we determined whether targeted disruption of the clock genes, Per1 and/or Per2, alters toxin-induced expression of known biological markers in the AhR signaling pathway. 2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD), a prototypical Ahr agonist, had an inductive effect on mammary gland expression of cytochrome P450, subfamily I, polypeptide 1 (Cyp1A1) mRNA regardless of genotype. However, TCDD-mediated Cyp1A1 induction in the mammary glands of Per1 ldc and Per1 ldc /Per2 ldc mice was significantly (17.9-and 5.9-fold) greater than that in wild-type (WT) animals. In addition, TCDD-induced Cyp1B1 expression in
Per1
ldc and Per1 ldc /Per2 ldc mammary glands was significantly increased relative to that in WT mice. Similar to in vivo observations, experiments using primary cultures of mammary gland tissue demonstrated that TCDD-induced Cyp1A1 and Cyp1B1 expression in Per1 ldc and Per1 ldc /Per2 ldc mutant cells was significantly greater than that in WT cultures. AhR mRNA levels were distinctively elevated in cells derived from all mutant genotypes, but they were commonly decreased in WT and mutant cultures after TCDD treatment. In WT mice, an interesting corollary is that the inductive effects of TCDD on mammary gland expression of Cyp1A1 and Cyp1B1 vary over time and are significantly greater during the night. These findings suggest that clock genes, especially Per1, may be involved in TCDD activation of AhR signaling pathways.
Members of the Per-Arnt-Sim (PAS) family of transcriptional regulators are involved in development and in sensing and adapting to environmental conditions. PAS proteins control diverse biological processes such as morphogenesis, circadian rhythms, and responses to hypoxia and toxins (Crews and Fan, 1999) . The PAS domain is a multifunctional protein motif governing ligand and DNA binding as well as interactions between PAS and non-PAS proteins. Most PAS proteins function as heterodimers consisting of a sensor protein associated with a general binding partner. For example, the aryl hydrocarbon receptor (AhR) partners with the AhR nuclear translocator (Arnt) to mediate the transcriptional activation of xenobiotic-metabolizing enzymes, whereas circadian locomotor output cycles kaput (Clock) associates with brain, muscle ARNT-like protein 1 (Bmal1) to form core elements of the circadian clock mechanism in mammals. Not surprisingly, PAS protein-regulated pathways are interconnected through a variety of mechanisms, including competition for binding partners (Woods and Whitelaw, 2002) , functional interference (Moffett et al., 1997) , direct interaction (Hogenesch et al., 1998) , and transcriptional regulation (Chilov et al., 2001) .
The importance of the PAS genes AhR and Arnt responding to environmental toxins such as polycyclic aromatic hydro-carbons (PAHs) is well documented. After entry into the cell, PAHs bind the AhR, which is complexed with 90-kDa heat shock proteins and the aryl hydrocarbon receptor-interacting protein. Upon ligand binding, this complex dissociates, and PAH-bound AhR translocates to the nucleus and partners with ARNT. AhR-ARNT heterodimers bind to xenobiotic response elements in target gene promoters affecting their expression. Principal targets of AhR signaling are cytochrome P450 enzymes of the A and B subfamily, including Cyp1A1, Cyp1A2, and Cyp1B1. Cytochromes P450 catalyze oxidation of PAHs to reactive metabolites suitable for conjugation by phase II detoxifying enzymes, including glutathione transferases and UDP-glucuronosyltransferases. The resulting conjugates are generally less reactive, more hydrophilic molecules that are easier to excrete. If not rendered less reactive or excreted, oxidative PAH metabolites can form DNA adducts, leading to mutations and increased cancer risk.
The PAS genes Clock, Bmal1, Period 1 (Per1), and Per2 are important components of the circadian clock mechanism in mammals. These PAS genes form interacting positive-and negative-feedback loops in which the transcription of core components is rhythmically regulated by their protein products. PER1 and PER2 form heterodimeric complexes with the protein products of the cryptochrome (Cry) genes, and after a delay, these complexes are translocated to the nucleus (Kume et al., 1999; Yagita et al., 2000) . CRY proteins then inhibit the transcription of Clock and Bmal1 (Griffin et al., 1999) . In turn, CLOCK and BMAL1 close the feedback loop by forming heterodimers that positively regulate the rhythmic transcription of the Per and Cry genes via the activation of E-box elements (Gekakis et al., 1998; Hogenesch et al., 1998; . CLOCK:BMAL1 complexes also mediate the activation of clock-controlled genes that serve as outputs from the clock and function to regulate downstream rhythmic processes throughout the body.
Recent evidence suggests that molecular components of the circadian clock serve important functions in other PAS generegulated processes, including development, tumorigenesis, and drug metabolism. For example, Per1 and Per2 have been implicated in mammary gland development and differentiation based on changes in their expression during different stages of development and of the cell cycle. Per1 and Per2 involvement in the regulation of neoplastic growth is supported by the observations that Per2-deficient mice are more susceptible to the development of spontaneous and ␥-radiation-induced tumors (Fu et al., 2002) and that PER1 and PER2 expression is down-regulated in human breast tumors relative to normal surrounding tissue (Chen et al., 2005) .
Because PAHs are potent carcinogens, and PAS proteins can interact with one another, we examined whether core elements of the clock mechanism also play some role in PAH responses mediated by the PAS gene AhR. Previous studies indicate that Drosophila melanogaster PER forms dimers with AhR and ARNT via the PAS domain, and this process interferes with the DNA binding activity of AhR/ARNT heterodimers (Lindebro et al., 1995) . Clock gene function in AhR signaling is also suggested by studies demonstrating that BMAL1 interacts with AhR (Hogenesch et al., 1997) . Consequently, experiments were conducted to determine whether targeted disruption of the clock genes, Per1 and/or Per2, affects the activation of cytochromes P450 and other components of the AhR signaling pathway in the mammary gland by the protypical AhR ligand 2, 3, 7, . Our results demonstrate that disruption of the circadian clock produces hyperinduction of host responsiveness to environmental toxicants.
Materials and Methods

Animals
Experimental subjects were female wild-type (WT) 129/sv mice (n ϭ 38) purchased from Charles River Laboratories, Inc. (Wilmington, MA) and Per1 ldc , Per2 ldc , and Per1 ldc /Per2 ldc mutant mice (each n ϭ 18) derived from breeding pairs generously provided by Dr. David Weaver (University of Massachusetts Medical School, Worcester, MA). Establishment and characterization of these transgenic mice have been described previously (Bae et al., 2001) . Animals were maintained in the vivarium at Texas A&M University System Health Science Center (College Station, TX) under a standard 12-h light:dark cycle (lights-on at 6:00 AM) with access to food and water ad libitum. Procedures used in this study were approved by the University Laboratory Animal Care Committee at Texas A&M University. Responses of the AhR signaling pathway were examined in 8-week-old female mice treated with TCDD (provided by Dr. Stephen Safe, School of Veterinary Medicine, Texas A&M University) at a dose of 10 g/kg body weight. Previous studies showed a single dose of 5 g/kg TCDD or higher for 24 h significantly induces hepatic Cyp1A1 expression in mice (Narasimhan et al., 1994 ). In the current study, animals received an intraperitoneal injection of vehicle (corn oil) or TCDD approximately 6 h after lights-on in the 12-h light/dark cycles (12:00 PM; zeitgeber time [ZT] 6). Twenty-four hours after treatment, animals were sacrificed by cervical dislocation at ZT 6), and mammary gland tissues were collected in RNA Stabilization Reagent (RNAlater; QIAGEN, Valencia, CA) for later extraction of total RNA. For each tissue sample, approximately 30 mg of mammary tissue was homogenized and processed for extraction of total cellular RNA using the RNeasy Lipid Tissue Mini kit (QIAGEN). The final RNA pellet was subjected to on-column DNase digestion (QIAGEN), suspended in 100 l of RNase-free water, and then it was stored at Ϫ80°C. Mammary gland cells were collected from 12-to 14-week-old female mice, and primary cultures of these cells were established using methods similar to those described previously (Pullan and Streuli, 1996; Seagroves et al., 1998) . For each experiment, mammary gland cultures were obtained from WT mice and compared with those from the mutant mice (Per1 ldc , Per2 ldc , or Per1 ldc /Per2 ldc ) at the same age (each n ϭ 3). In brief, cells were extracted from mouse mammary glands and cultured on serum/fetuin-coated six-well plates in Dulbecco's modified Eagle's medium/Ham's F-12 medium (Invitrogen, Carlsbad, CA) containing 5 g/ml insulin (Sigma-Aldrich, St. Louis, MO), 1 g/ml hydrocortisone (Sigma-Aldrich), 5 ng/ml epithelial growth factor (QED/Advanced Research Technologies, San Diego, CA), 50 g/ml gentamicin (Invitrogen), 100 U/ml penicillin/streptomycin (Invitrogen), and 5% fetal bovine serum at 37°C in a humidified incubator with 5% CO 2 . Confluent cultures were treated with vehicle [n ϭ 3; dimethyl sulfoxide (DMSO); Sigma-Aldrich] or 20 nM TCDD (n ϭ 3) for 24 h. After treatment, cultures were collected by trypsinization, and total RNA was extracted using RNeasy Mini kit (QIAGEN). The dose and duration of TCDD treatment in these experiments were based on previous observations indicating that robust increases in Cyp1A1 and Cyp1B1 mRNA and protein levels occur within human mammary epithelial cells in vitro after exposure to TCDD for 24 h (Chen et al., 2004) .
Experiment 3: Time-Dependent Effects of TCDD Treatment on the AhR Signaling Pathway in the Mouse Mammary Gland in Vivo
To determine whether TCDD-induced effects on the AhR signaling pathway in vivo vary as a function of treatment time, WT mice were injected intraperitoneally with vehicle or 10 g of TCDD/kg of b.wt. at the midpoint of either the light phase (12:00 PM; ZT 6; n ϭ 22) or dark phase [12:00 AM (midnight); ZT 18; n ϭ 12], and mammary gland tissues were collected 24 h after treatment as described in experiment 1.
Quantitative Reverse Transcription-Polymerase Chain Reaction Analysis. Quantification of relative mRNA abundance was performed using SYBR Green real-time PCR technology (Applied Biosystems, Foster City, CA) as described previously (Metz et al., 2006) . Total RNA (1 g) was reverse transcribed using Superscript II (Invitrogen) and random hexamers. For each sample, the cDNA equivalent to 1.25 ng of total RNA per 12.5-l reaction was amplified in an ABI 7500 Fast Real-Time PCR system using 9600 emulation modes. To control for differences in sample RNA content, cyclophilin A (CypA), or ␤-actin was amplified from the same samples. Primer sequences for PCR amplification of target and control genes are listed in Table 1 .
The comparative C T method was used to calculate the relative mRNA abundance for a given target gene. Using this method, the amount of target gene mRNA in each sample was normalized first to corresponding CypA or ␤-actin mRNA levels, and then relative to a calibrator consisting of pooled cDNA from multiple samples that was analyzed on each reaction plate.
Statistical Analysis
In experiments 1 and 2, statistical analyses were first performed on the raw data using two-way analyses of variance (ANOVAs) with treatment (vehicle versus TCDD) and genotype (WT, Per1 ldc , Per2 ldc , and Per1 ldc /Per2 ldc ) as two independent variables. If significant main effects of treatment were identified, planned comparisons using independent t tests were applied to compare gene expression between control and TCDD groups of the same genotype. The -fold differences in gene expression between these treatment groups were then analyzed using one-way ANOVA, and, if required, Fisher's least significant difference post hoc analyses to determine whether genotype had a significant effect on TCCD-induced changes in mRNA levels for a given gene. In experiment 3, the raw data were first analyzed using two-way ANOVAs, with treatment (vehicle versus TCDD) and time (ZT 6 versus ZT 18) as two independent variables. If significant main effects were identified, planned comparisons using independent t tests were applied to compare gene expression between control and TCDD groups at the same treatment time. For the P450 genes, the -fold differences in TCDD-induced gene expression were also analyzed using independent t tests to determine the significance of treatment time. The ␣ value was set at 0.05 for all statistical analyses. (Bae et al., 2001) . Consistent with previous findings (Narasimhan et al., 1994) , basal levels of Cyp1A1 mRNA expression were observed in the mammary glands of all vehicle-treated WT and mutant mice (Fig. 1A) . Relative to vehicle controls, TCDD had a robust effect in inducing Cyp1A1 expression within the mammary gland. In both WT and mutant mice, mammary gland levels of Cyp1A1 mRNA were significantly greater (p Ͻ 0.05) in TCDD-treated animals than in vehicle controls. Genotype-related differences were evident in the absolute values of TCDD-induced Cyp1A1 expression in the mammary gland (Fig. 1A) . In the mammary glands of Per1 ldc and Per1 ldc /Per2 ldc mutant mice, the TCDD-induced Cyp1A1 expression was significantly (p Ͻ 0.05) and approximately 3 times higher than that found in WT animals. Analysis of the -fold difference in gene expression between the TCDD-and vehicle-treated groups for each genotype revealed further distinctions in the activation of the AhR signaling pathway among mutant mice with targeted disruptions of the Per1 and Per2 genes (Fig. 1B) . The -fold differences in the TCDD-induced Cyp1A1 expression within the mammary gland were significantly greater in Per1 ldc (p Ͻ 0.05) and Per1 ldc /Per2 ldc (p Ͻ 0.05) mutant mice than in WT animals. In fact, the inductive effects of TCDD on Cyp1A1 expression within the mammary glands of Per1 ldc and Per1 ldc /Per2 ldc mutant mice were increased by 17.9-and 5.9-fold, respectively, relative to that found in WT mice.
Results
Effects of Targeted Disruption of
TCDD-mediated effects on mammary gland expression of another P450 gene in the AhR signaling pathway, Cyp1B1, followed a similar trend. Cyp1B1 mRNA levels in the mammary gland were consistently low and similar among all vehicle-treated WT and mutant mice (Fig. 1A) . In comparison with vehicle controls, TCDD treatment produced significant increases (p Ͻ 0.05) in mammary gland levels of Cyp1B1 mRNA in Per1 ldc and Per1 ldc /Per2 ldc mice but not in WT and Per2 ldc animals. Despite the lack of significant variation among genotype-based comparisons, the -fold differences in TCDD-induced Cyp1B1 expression within the mammary glands of Per1 ldc and Per1 ldc /Per2 ldc mutant mice was increased by 2.5-and 2.2-fold, respectively, relative to that found in WT animals (Fig. 1B) .
Two major regulators of TCDD-induced responses, AhR and Arnt were also analyzed in our study. Similar levels of AhR expression were observed in mammary glands of all vehicle-treated WT and mutant mice (Fig. 2) . No significant differences in mammary gland levels of AhR mRNA were evident among vehicle control and TCCD-treated mice, regardless of their genotype. Similar to AhR, Arnt mRNA expression in the mammary gland was comparable in all mice, with no major treatment-or genotype-based differences (Fig. 2) . Effects of Targeted Disruption of Per1, Per2, and Per1/Per2 on TCDD-Activated AhR Signaling Pathway in Primary Cultures of the Mouse Mammary Gland. Because the AhR signaling pathway is influenced by steroid hormones such as glucocorticoids and 17␤-estradiol in vivo (Gorski et al., 1988; Christou et al., 1995; Prough et al., 1996) and because serum levels and the rhythmic regulation of steroid hormones are altered in Per1-deficient mice (Dallmann et al., 2006) , parallel in vitro analysis was conducted to indirectly address the role of Per-mediated hormonal changes in the potentiation of TCDD-induced AhR signaling in mutant mice. Primary cultures of the mouse mammary gland were used to determine whether the observed amplification of TCDD-induced P450 expression in Per mutant mice per- The plotted values for the relative mRNA abundance correspond to the ratios of species-specific Cyp1A1 or Cyp1B1/CypA mRNA signal that were adjusted in relation to the average for TCCD-treated WT mice, which was arbitrarily set at 100. The values for -fold differences in TCDD-induced Cyp1A1 expression are represented at 100ϫ. Asterisks denote comparisons for each genotype, in which P450 gene expression in the mammary gland of TCDD-treated mice was significantly greater (p Ͻ 0.05) than that observed in oil-treated controls. For each genotype, -fold differences in P450 gene expression between the TCDD-and oil-treated groups were determined by normalizing all values to the average of oil-treated controls, which was arbitrarily set at 1. The -fold differences in the TCDD-induced Cyp1A1 and Cyp1B1 expression within the mammary gland were significantly greater in Per1 ldc and Per1 ldc /Per2 ldc ( †, p Ͻ 0.05) mutant mice than in WT animals.
sists in vitro in the absence of hormonal influences. Basal levels of Cyp1A1 expression were observed among all vehicletreated mammary gland cultures derived from WT and mutant animals (Fig. 3A) . Relative to vehicle controls, treatment with 20 nM TCDD for 24 h induced significant increases (p Ͻ 0.05) in Cyp1A1 expression in all mammary gland cultures. Genotype-based distinctions were evident in the -fold differences in Cyp1A1 expression between TCDD-and vehicletreated cultures. Consistent with the results of our in vivo study, the -fold differences in the TCDD-induced Cyp1A1 expression were significantly greater in mammary gland cultures derived from Per1 ldc and Per1 ldc /Per2 ldc (p Ͻ 0.05) mutant mice than in those from WT animals (Fig. 3B) . The TCDD-mediated induction of Cyp1A1 mRNA levels was 5.7-and 4.2-fold higher in Per1 ldc and Per1 ldc /Per2 ldc mammary cells than in WT cultures. In mammary gland cultures from Per2 ldc mice, the -fold differences in the induction of Cyp1A1 expression by TCDD were reduced relative to WT cells. Similar to Cyp1A1, Cyp1B1 expression was consistently low in vehicle-treated mammary cells (Fig. 3A) . TCDD had a significant effect in inducing Cyp1B1 expression in all WT and mutant cultures (p Ͻ 0.05). Interactions between treatment and genotype were comparable with those observed in vivo. TCDD treatment produced increases in Cyp1B1 expression in Per1 ldc and Per1 ldc /Per2 ldc mammary cells that were significantly greater (p Ͻ 0.05) than those found in WT cultures (Fig. 3A) . Further analysis revealed that the -fold differences in TCDD-induced Cyp1B1 expression were significantly greater (p Ͻ 0.05) in Per1 ldc and Per1 ldc /Per2 ldc mammary gland cultures than in WT cells (Fig. 3B) . The -fold differences in TCDD-mediated Cyp1B1 induction in Per1 ldc and Per1 ldc /Per2 ldc cells were 2.3 and 3.9 times higher, respectively, than that in WT cultures.
The central regulators of TCDD-induced signaling, AhR and Arnt, were differentially expressed and affected by this toxin in primary cultures of the mouse mammary gland. Among vehicle-treated mammary cells, it is interesting that AhR mRNA expression in all mutant cultures were significantly greater (p Ͻ 0.05) than WT levels. The highest levels of AhR expression in vehicle-treated cells were observed in cultures derived from Per1 ldc mice. TCDD had a significant effect in reducing AhR mRNA levels in both WT and mutant mammary cells (p Ͻ 0.05) (Fig. 4) . In response to TCDD exposure, AhR expression was reduced to comparable levels among WT and mutant cells, with exception of cultures derived from Per1 ldc mice. After treatment, AhR mRNA levels in Per1 ldc mammary gland cultures were significantly (approximately 2 times) higher (p Ͻ 0.05) than those found in WT cells exposed to TCDD. In contrast to AhR, there was no significant effect of either treatment or genotype on Arnt expression in mammary gland cultures (Fig. 4) . Similar levels of Arnt mRNA were expressed by both WT and mutant cells after treatment with vehicle or TCDD.
Time-Dependent Effects of TCDD Treatment on the AhR Signaling Pathway in the Mouse Mammary Gland in Vivo.
Because the results of our in vivo and in vitro experiments indicate that changes in Per gene expression affect TCDD-induced responses of the AhR signaling pathway, we next determined whether the inductive effects of this toxin on P450 gene expression vary endogenously in accord with the diurnal Per rhythms that are known to occur in mouse mammary gland (Metz et al., 2006) . In oil-injected WT mice, Cyp1A1 mRNA levels in the mammary gland were low irrespective of treatment time (Fig. 5A) . TCDD administered during the day and at night both triggered significant increases in mammary gland levels of Cyp1A1 mRNA (p Ͻ 0.05). It is noteworthy that treatment time had a significant effect (p Ͻ 0.05) on the -fold differences in the TCDD-mediated Cyp1A1 induction in the mammary gland such that the increase in the expression of this P450 gene triggered by toxin injection at ZT 18 was 8.6-fold higher than that after treatment at ZT 6 (Fig. 5B) . Unlike the pattern for Cyp1A1, Cyp1B1 expression in the mammary glands of vehicletreated animals was marked by significant variation over time (p Ͻ 0.05) with mRNA levels at ZT 6 that were substantially greater than those at ZT 18. Consequently, TCDD had no significant effects on mammary gland levels of Cyp1B1 mRNA when treatment was administered at ZT 6, but it The plotted values for the relative mRNA abundance correspond to the ratios of species-specific AhR or Arnt/CypA mRNA signal that were adjusted in relation to the average for TCCD-treated WT mice, which was arbitrarily set at 100. TCDD treatment or genotype had no significant effects on mammary gland levels of AhR and Arnt mRNA.
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at ASPET Journals on September 30, 2017 molpharm.aspetjournals.org Downloaded from induced significant increases (p Ͻ 0.05) in expression of this P450 gene after exposure at ZT 18 (Fig. 5A) . Moreover, the -fold differences of TCDD-induced Cyp1B1 expression within the mammary gland at ZT 18 were significantly (p Ͻ 0.05) and approximately 2 times higher than those observed at ZT 6 (Fig. 5B) .
AhR expression in the mammary gland was also marked by time-dependent variation in vehicle-treated WT mice. AhR mRNA levels in the mammary glands of vehicle controls were significantly greater during the day at ZT 6 than during the night at ZT 18 (P Ͻ 0.05) (Fig. 6) . TCDD administration did not alter AhR expression in the mammary gland and no time-dependent differences were evident in its effects on this gene. In vehicle-treated mice, Arnt expression in the mammary gland showed no sign of diurnal variation (Fig. 6) . Arnt mRNA levels in the mammary gland were not affected by TCDD administration or the time of treatment.
Discussion
Previous studies have linked the PAS genes Per1, Per2, Bmal1, and Clock not only with the generation of circadian rhythms but also with the regulation of various nonclock functions. Mice with deletions or mutations of these genes Fig. 3 . Effects of targeted mutations of Per1, Per2, and Per1/Per2 on TCDD-mediated induction of P450 genes in mouse mammary cells in vitro. For Cyp1A1 and Cyp1B1, the relative mRNA abundance (A) and -fold differences (B) in their expression after TCDD treatment were analyzed in primary cultures of mammary tissue derived from WT, Per1 ldc , Per2 ldc , or Per1 ldc /Per2 ldc mice. Data are expressed as the mean Ϯ S.E.M. for each experimental group. The plotted values for the relative mRNA abundance correspond to the ratios of species-specific Cyp1A1 or Cyp1B1/␤-actin mRNA signal that were adjusted in relation to the average for TCCD-treated cells from WT mice, which was arbitrarily set at 100. Asterisks denote comparisons for each culture genotype, in which P450 gene expression in TCDD-treated mammary cells was significantly greater (p Ͻ 0.05) than that observed in DMSO-treated cultures. The -fold differences in P450 gene expression between the TCDD-and DMSO-treated cultures of each genotype were determined by normalizing all values to the average of DMSO-treated controls, which was arbitrarily set at 1. The -fold differences in TCDD-induced Cyp1A1 and Cyp1B1 expression were significantly greater ( †, p Ͻ 0.05) in Per1 ldc and Per1 ldc /Per2 ldc mammary gland cultures than in WT cells.
exhibit alterations in the circadian regulation of locomotor activity (Bae et al., 2001; Reppert and Weaver, 2002) in conjunction with a myriad of other physiological or behavioral disturbances, including decreased body weight, shortened life span, increased tendon calcification (McDearmon et al., 2006) , premature aging, tissue hyperplasia (Fu et al., 2002; Lee, 2006) , increased alcohol consumption (Spanagel et al., 2005) , and altered responses to other drugs of abuse (Kondratov et al., 2007) . Consistent with these observations, the present study revealed that targeted disruption of the Per genes modifies mammary gland responses to the environmental toxin TCDD. It is interesting that the inductive effects of TCDD on expression of the cytochrome P450 genes Cyp1A1 and Cyp1B1 were potentiated in mammary glands and in primary cultures of mammary cells from Per1 ldc and Per1 ldc /Per2 ldc , but not Per2 ldc , mice. Similar to primary analyses of these mutant mice indicating that the Per1 and Per2 genes influence different molecular processes but are indispensable for normal clock function (Shearman et al., 2000; Bae et al., 2001; Zheng et al., 2001) , our findings suggest that Per1 plays a distinct role in modulating TCDD activation of the AhR signaling pathway.
The mechanism by which the Per genes interact with components of the AhR signaling pathway and influence its activation by TCDD is currently unknown. However, a possible explanation is that the potentiation of TCDD-induced Cyp1A1 and Cyp1B1 expression in the mammary gland is associated with the altered function of the circadian clockworks in Per1 ldc and Per1 ldc /Per2 ldc mice. Similar to the findings of Bae et al. (2001) , these mutant mice exhibited arrhythmic patterns of wheel-running activity after 1 to 2 weeks of exposure to constant darkness (data not shown). Because up to 10% of the transcriptome is clock-controlled in peripheral tissues (Duffield, 2003) and some of these genes with oscillatory profiles are essential elements of critical biochemical processes mediating drug metabolism and responses to xenobiotic agents (Gachon et al., 2006; Menger et al., 2007) , the disruptive effects of the Per1 mutation on circadian clock function may extend to the rhythmic regulation of the AhR signaling pathway in Per1 ldc and Per1 ldc / Per2 ldc mice. This hypothesis is indirectly supported by the present observations that AhR expression and TCDD-mediated induction of P450 genes in the mammary gland are marked by diurnal variation. In the mammary glands of WT mice, AhR mRNA levels are lower and TCDD-induced Cyp1A1 and Cyp1B1 expression is greater during the night than during the day. Because the diurnal variation in the TCDD-mediated P450 induction in the mammary gland is inversely related to the temporal pattern of Per1 gene expression, in which tissue mRNA levels peak during the day and remain low throughout the night (Metz et al., 2006) , the disruption of Per1 expression and rhythmicity in Per1 ldc and Per1 ldc /Per2 ldc mice may be responsible for the potentiated activity of the AhR signaling pathway in response to this toxin. To further explore this possibility, it will be necessary to determine whether the rhythmic variation in TCDD-induced P450 gene expression in the mammary gland is also abolished in (Gorski et al., 1988; Christou et al., 1995; Prough et al., 1996) and that steroid hormone levels and cycles are altered in Per1-deficient mice (Dallmann et al., 2006) . However, the results of our in vitro study do not seem to support this possibility, because the potentiation of TCDD-induced Cyp1A1 and Cyp1B1 expression persists in mammary cultures from these mutant mice despite the absence of hormonal signals that occur in vivo.
On the other hand, the potentiation of TCDD-induced P450 gene expression in Per1 ldc and Per1 ldc /Per2 ldc mice may not be associated with the disruption of the circadian clockworks but instead be related to changes in Per gene interactions with specific components of the AhR signaling pathway. Our findings raise the possibility that Per1 may directly inhibit TCDD activation of the AhR signaling pathway. This inhibition could occur via interactions between Per1 and PAS gene components of the AhR signaling pathway at several different levels. Because the function of PER1 in regulating circadian rhythmicity is distinctly mediated through its interactions with other PAS proteins in the feedback loop (Bae et al., 2001 ), PER1 may similarly interact with the PAS proteins AhR and ARNT and perhaps inhibit their dimerization. Per1 may also directly influence the AhR signaling pathway by inhibiting the binding of AhR:ARNT complexes to the dioxin response elements of target genes. This hypothesis is corroborated by the observation that D. melanogaster PER impedes the formation and DNA binding activity of AhR:ARNT complexes by dimerizing with AhR and ARNT via the PAS domain (Lindebro et al., 1995) . Our in vitro results suggest that AhR expression is another prospective target for Per1 in Fig. 5 . Effects of treatment time on TCDD-mediated induction of P450 genes in the mouse mammary gland. For Cyp1A1 and Cyp1B1, the relative mRNA abundance (A) and -fold differences (B) in their expression after TCDD treatment during the daytime (ZT 6) and nighttime (ZT 18) were analyzed in the mammary glands of WT mice. Data are expressed as the mean Ϯ S.E.M. for each experimental group. The plotted values for the relative mRNA abundance correspond to the ratios of species-specific Cyp1A1 or Cyp1B1/CypA mRNA signal that were adjusted in relation to the average for WT mice exposed to TCDD at ZT 6, which was arbitrarily set at 100. The values for -fold differences in TCDD-induced Cyp1A1 expression are represented at 100ϫ. Asterisks denote treatment times, in which TCDD induced significant (p Ͻ 0.05) increases in Cyp1A1 and Cyp1B1 expression within the mammary gland relative to that observed in oil-treated controls. For each treatment time, -fold differences in P450 gene expression between the TCDD-and oil-treated groups were determined by normalizing all values to the average of oil-treated controls, which was arbitrarily set at 1. The -fold differences in the TCDD-induced Cyp1A1 and Cyp1B1 expression within the mammary gland were significantly greater ( †, p Ͻ 0.05) during the night at ZT 18 than during the day at ZT 6. down-regulating TCCD-mediated activation of the AhR signaling pathway, because AhR mRNA expression in mammary gland cells derived from Per1 ldc , Per2 ldc and Per1 ldc / Per2 ldc mutant mice was substantially higher than that found in WT cultures. Further analysis will be necessary to specifically determine whether the Per genes modulate TCDD-mediated induction of P450 gene expression by inhibiting AhR expression, the formation of AhR:ARNT heterodimers, or the binding of these complexes with DREs.
In summary, our data indicate that the targeted disruption of Per1 potentiates the inductive effects of TCDD on P450 gene expression in the mammary gland in vivo and in vitro. Because the induced expression of the P450 genes Cyp1A1 and Cyp1B1 has been associated with increased cancer risk (Schrenk, 1998) , this finding may have further implications for the involvement of the Per genes in carcinogenesis. Previous studies have shown that Per2 suppresses tumor development by regulating responses to DNA damage (Fu et al., 2002) . Moreover, human breast cancer tissue is distinguished by Per1 promoter methylation and associated alterations in PER1 protein levels relative to that found in adjacent normal cells (Chen et al., 2005) . Together with the present evidence for diurnal fluctuations in AhR expression and TCDD-induced Cyp1A1 and Cyp1B1 expression within the mammary gland, these observations suggest that the Per genes, perhaps via their function in the circadian clockworks, may play an important role in regulating responses to environmental toxins and in modulating their carcinogenic effects. Fig. 6 . Time-dependent effects of TCDD treatment on AhR and Arnt mRNA expression in the mouse mammary gland. The relative abundance of AhR and Arnt mRNA in the mammary glands of WT mice was analyzed in response to TCDD treatment during the daytime (ZT 6) or nighttime (ZT 18). Data are expressed as the mean Ϯ S.E.M. for each experimental group. The plotted values for the relative mRNA abundance correspond to the ratios of species-specific AhR or Arnt/CypA mRNA signal that were adjusted in relation to the average for WT mice treated with TCDD at ZT 6, which was arbitrarily set at 100. In oil-treated controls, mammary gland levels of AhR mRNA at ZT 18 were significantly lower (p Ͻ 0.05) than that observed at ZT 6. TCDD and treatment time had no significant effect on Arnt mRNA expression in the mammary gland. 
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